For many years, healthcare largely adopted a reactive mannequin, intervening as soon as illness manifests. However with over 5.8 million annual deaths from non-communicable ailments (NCDs), rising metabolic problems, infertility challenges, lifestyle-linked power situations, and an getting older inhabitants, the nation is witnessing a decisive shift towards preventive, science-backed healthcare.
On the heart of this transformation stands Universal NutriScience (UNS), an organization redefining nutraceuticals from “adjunct dietary supplements” to clinically validated therapeutic options.
From Shopper Dietary supplements to Clinical Science
India’s nutraceutical universe stays predominantly shopper pushed. Almost 70–80% of the market flows immediately by retail channels, with solely 20–30% routed by docs below scientific supervision.
This structural imbalance usually outcomes in inconsistent dosing, variable outcomes, and restricted medical oversight.
UNS has intentionally positioned itself in the extra demanding however much more credible section, doctor-driven, evidence-based nutraceuticals.
Reasonably than competing in commoditized over-the-counter wellness, UNS has constructed a pure-play, therapy-focused platform anchored in:
- Randomized medical proof
- Outlined dosage protocols
- Pharmaceutical-grade manufacturing
- Novel Drug Supply Programs (NDDS)
- Measurable therapeutic outcomes
Trendy healthcare practitioners demand proof. Sufferers demand security. The nutraceutical trade is present process a “pharmaceuticalization,” mixing the security of pure compounds with the rigor of medical science. UNS is on the forefront of this shift.This mannequin is especially highly effective in power and lifestyle-linked situations the place:
- Lengthy-term drug remedy has security limitations
- Life-style intervention is important
- Preventive assist can delay invasive procedures
Universal NutriScience: Constructing India’s Most Trusted Nutraceutical Platform
Born from a strategic partnership between Kedaara Capital and Universal Medicare, UNS has quickly emerged as a science-led, innovation-driven nutraceutical platform.
With a 30-year manufacturing heritage, entry to world-class R&D infrastructure, and powerful personal fairness backing, UNS combines:
- Scientific rigor
- Therapeutic specialization
- Area execution power
- Digital-forward engagement
- Structured expertise structure
UNS just isn’t chasing tendencies, it’s shaping therapeutic classes.Dominance in Girls’s Well being & Fertility
Infertility is not a distinct segment concern. Delayed parenthood, stress, metabolic problems, and environmental components have made reproductive well being a rising public well being precedence.
UNS has carved a management place in fertility science by its dominant presence in Coenzyme Q10 (CoQ).
CoQ: From Early Intervention to Superior Assist
CoQ performs a central function in mitochondrial vitality manufacturing, immediately influencing:
- Oocyte high quality
- Sperm motility
- Sperm depend
- Oxidative stress steadiness
UNS’ CoQ portfolio is designed throughout your complete fertility journey, from early analysis to superior assisted reproductive phases.Its remedy protection spans:
- Couple remedy frameworks
- Assist in Poor Ovarian Response
- Assist for diminishing ovarian reserve
- Libido administration
- Erectile dysfunction assist
- Sperm parameter optimization
- Sperm depend enhancement
This stage-wise therapeutic protection displays a continuum-of-care philosophy, not remoted product promoting.
The outcome: clinically supervised nutraceutical intervention built-in into reproductive protocols quite than positioned as common supplementation.
Girls’s Well being: Addressing the Silent Burden
India’s demographic profile underscores the magnitude of unmet want.
Girls aged 15–44 years symbolize almost 22% of the inhabitants, roughly 330 million people. Inside this group:
- Almost 45% expertise Premenstrual Syndrome (PMS)
- Solely about 27% are formally recognized
- Lower than 10% obtain structured therapy
Thousands and thousands silently endure cyclical ache, mastalgia, benign breast problems, hormonal imbalance, and lowered high quality of life.
UNS has addressed this hole by clinically supported hormonal wellness options, together with GLA-rich Night Primrose Oil formulations, positioned below medical steerage.
This isn’t symptom masking.
It’s structured hormonal assist rooted in scientific proof.
Sakhi: Science with Social Accountability
Past business ambition, UNS acknowledges its social duty.
By way of its Sakhi CSR initiative, the corporate drives consciousness and schooling round menstrual well being and hormonal wellness throughout, Faculties, Faculties and Rural communities
Sakhi focuses on:
- Early symptom recognition
- Decreasing stigma
- Bettering analysis charges
- Selling protected therapeutic pathways
By extending preventive science past prescriptions, UNS is strengthening community-level healthcare literacy whereas reinforcing its long-term therapeutic ecosystem.
Preventive Orthopedics: Delaying Invasive Interventions
India’s osteoarthritis burden is increasing quickly.
UNS’ collagen portfolio helps cartilage well being by optimized bioavailability and high quality sourcing. Beneath medical supervision, structured collagen supplementation can assist delay invasive procedures corresponding to Complete Knee Substitute (TKR) in choose affected person populations.
This represents preventive orthopedics, proactive joint preservation quite than post-surgical restoration.
Normal Wellness: From Legacy Manufacturers to Life-style Interventions
Immunity consciousness post-pandemic reshaped shopper habits completely.
UNS manufacturers corresponding to Seacod (Cod liver oil / fish oil) proceed to see robust choice amongst youngsters and adults for immunity and metabolic assist.
However the shift is deeper, these merchandise are not “seasonal immunity boosters.” They’re every day life-style interventions built-in into preventive healthcare routines.
Management Views
The CEO’s Imaginative and prescient: Pratin Vete on Scaling with Goal
With management stints throughout world and Indian pharma majors together with Novartis, Sanofi, Cipla, and Emcure, CEO Pratin Vete brings a transformational mindset to UNS.
He believes nutraceuticals are not non-obligatory adjuncts, they’re preventive pillars.
“There’s a clear and rising medical acceptance of nutraceuticals as preventive and supportive therapies. Throughout COVID, immunity-supporting therapies witnessed exponential demand. Even as we speak, shoppers actively search evidence-backed options.”
He emphasizes that nutraceuticals meaningfully complement prescription drugs in bettering remedy outcomes, whether or not in fertility, osteoarthritis, PMS, or metabolic well being.
“Our objective is to construct a portfolio admired by each docs and sufferers. We’re strengthening digital engagement, scientific schooling, and discipline functionality to make sure UNS turns into the primary selection in preventive healthcare.”
The Strategic Outlook: Dr. Shailesh Ayyangar, Chairman, UNS on Precision Prevention & Innovation
Dr. Shailesh Ayyangar is aware of UNS manufacturers for greater than 15 years, having acquired this enterprise in 2010 when he was operating Sanofi enterprise in India. He strongly believes that way forward for holistic well being lies as a lot in evidence-based nutraceuticals as in science backed prescription drugs.
“India’s rising illness burden and ageing demographic demand research-driven preventive ideas. The subsequent decade belongs to evidence-based nutraceuticals which can be built-in into standard-of-care protocols.”
He believes the aggressive benefit lies not merely in product availability, however in scientific depth and disciplined execution.
“We’re not in the enterprise of promoting nutritional vitamins. We’re in the enterprise of delivering clinically related life-style interventions. The future is precision vitamin, proper molecule, proper affected person, proper stage of illness.”
Dr. Ayyangar credit UNS’s success to the R&D ecosystem of Universal Medicare, mixed with the strategic capital and governance self-discipline of Kedaara Capital which creates a uncommon mix of:
- Innovation functionality
- Manufacturing excellence
- Clinical credibility
- Scalable execution
“Our mission is to construct a nutraceutical platform that docs belief, sufferers depend on, and buyers consider in, throughout each stage of life.”
The UNS Development Trajectory: From Basis to ₹1000 Cr Imaginative and prescient
UNS isn’t just constructing manufacturers. It’s constructing therapeutic franchises.
With structured discipline enlargement, therapy-focused portfolio technique, digital-first engagement, and powerful expertise structure, the corporate is positioning itself to:
- Increase dominance in Girls’s Well being
- Deepen presence in Urology, Cardiovascular, Oncology & Diabetology adjacencies
- Strengthen Direct to Shopper (D2C) capabilities
- Leverage world sourcing & partnerships
- Scale towards a ₹1000 Cr ambition by FY28 – by natural and inorganic roadmap.
The group’s people-first tradition, management bench power, and performance-driven gross sales structure create the spine for sustainable scale.
Defining the New Commonplace of Care
As India accelerates towards preventive healthcare adoption, UNS just isn’t merely taking part in market development, it’s defining class benchmarks.
By way of scientific rigor, portfolio innovation, disciplined execution, and visionary management, Universal NutriScience is reworking nutraceuticals into an integral part of India’s healthcare continuum.
- From fertility to joint care.
- From hormonal steadiness to immunity.
- From supplementation to medical precision.
UNS is powering India’s shift from reactive medication to preventive science.
Source link
#Clinical #Pivot #Universal #NutriScience #Rewriting #Preventive #Healthcare #India
